You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Claims for Patent: 10,696,684

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 10,696,684

Title:	Process for preparing oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone
Abstract:	In certain embodiments the invention is directed to a process for preparing an oxycodone hydrochloride composition having less than 25 ppm of 14-hydroxycodeinone.
Inventor(s):	Chapman; Robert (Downingtown, PA), Rider; Lonn S. (Foster, RI), Hong; Qi (Sharon, MA), Kyle; Donald (Yardley, PA), Kupper; Robert (East Greenwich, RI)
Assignee:	PURDUE PHARMA L.P. (Stamford, CT) PURDUE PHARMACEUTICALS L.P (Wilson, NC) RHODES TECHNOLOGIES (Coventry, RI)
Application Number:	16/690,052
Patent Claims:	1. An oxycodone free base composition comprising oxycodone free base and 8.alpha.,14-dihydroxy-7,8-dihydrocodeinone, wherein following reacting the oxycodone free base composition with hydrochloric acid to form an oxycodone hydrochloride composition under reaction conditions capable of converting the 8.alpha.,14-dihydroxy-7,8-dihydrocodeinone to 14-hydroxycodeinone, the amount of 14-hydroxycodeinone that is present in the oxycodone hydrochloride composition is less than 100 ppm. 2. The oxycodone free base composition of claim 1, wherein the amount of 14-hydroxycodeinone that forms upon conversion of the oxycodone free base to the oxycodone hydrochloride is less than 25 ppm. 3. The oxycodone free base composition of claim 1, wherein the amount of 14-hydroxycodeinone that forms upon conversion of the oxycodone free base to the oxycodone hydrochloride is less than 10 ppm. 4. An oxycodone acid addition salt composition formed by reacting an oxycodone free base composition of claim 1 with an acid addition salt. 5. The oxycodone acid addition salt of claim 4, wherein the acid addition salt is hydrochloric acid. 6. The oxycodone acid addition salt of claim 4, wherein the acid addition salt is sulfuric acid. 7. An oxycodone acid addition salt composition formed by reacting an oxycodone free base composition of claim 2 with an acid addition salt. 8. The oxycodone acid addition salt of claim 7, wherein the acid addition salt is hydrochloric acid. 9. The oxycodone acid addition salt of claim 7, wherein the acid addition salt is sulfuric acid. 10. The oxycodone free base composition of claim 1, wherein following reacting the oxycodone free base composition with hydrochloric acid, the ratio of 8.alpha.,14-dihydroxy-7,8-dihydrocodeinone to the oxycodone hydrochloride is 0.04% or less as measured by HPLC. 11. An oxycodone free base composition comprising oxycodone free base and 8.alpha.,14-dihydroxy-7,8-dihydrocodeinone, wherein following reacting the oxycodone free base composition with hydrochloric acid to form an oxycodone hydrochloride composition under reaction conditions capable of converting the 8.alpha.,14-dihydroxy-7,8-dihydrocodeinone to 14-hydroxycodeinone, the ratio of 8.alpha.,14-dihydroxy-7,8-dihydrocodeinone to oxycodone hydrochloride is 0.04% or less as measured by HPLC. 12. The oxycodone free base composition of claim 11, which further comprises 14-hydroxycodeinone, and wherein the amount of 14-hydroxycodeinone is less than 25 ppm. 13. An oxycodone acid addition salt composition formed by reacting an oxycodone free base composition of claim 11 with an acid addition salt. 14. The oxycodone acid addition salt of claim 13, wherein the acid addition salt is hydrochloric acid. 15. The oxycodone acid addition salt of claim 13, wherein the acid addition salt is sulfuric acid. 16. An oxycodone free base composition comprising oxycodone free base and 8.alpha.,14-dihydroxy-7,8-dihydrocodeinone, wherein the ratio of 8.alpha.,14-dihydroxy-7,8-dihydrocodeinone to oxycodone is 0.04% or less as measured by HPLC. 17. The oxycodone free base composition of claim 16, which further comprises 14-hydroxycodeinone, and wherein the amount of 14-hydroxycodeinone is less than 25 ppm.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.